Abstract
The management of patients with intracerebral glioma is focused upon the selection of treatment modalities that prolong survival while minimizing the risk of complications and maintaining an adequate quality of life. In the author's experience, patients with low-grade gliomas are best treated with gross total resection in order to decrease the risk of recurrence with higher grade lesions. In patients with high-grade glioma, age, Karnofsky Performance Status, histology and the use of radiotherapy are major predictors of survival. The extent of surgical resection is less important than these factors, but recent series support a survival advantage in patients that undergo more extensive surgery. The major complication from surgical resection is neurologic impairment. Careful preoperative planning with the assistance of functional MRI and intraoperative mapping is useful for accomplishing the maximum safe resection.
Similar content being viewed by others
References
Mittler MA, Walters BC, Stopa EG: Observer reliability in histological grading of astrocytoma stereotactic biopsies. J Neurosurg 85: 1091–1094, 1996
Glantz MJ, Burger PC, Herndon JEI, Friedman AH, Cairncross JG, Vick NA, Schold SC, Jr.: Influence of the type of surgery on the histologic diagnosis in patients with anaplastic gliomas. Neurology 41: 1741–1744, 1991
Revesz T, Scaravilli F, Coutinho L, Cockburn H, Sacares P, Thomas DG: Reliability of histological diagnosis including grading in gliomas biopsied by image-guided stereotactic technique. Brain 116: 781–93, 1993
Chandrasoma PT, Smith MM, Apuzzo ML: Stereotactic biopsy in the diagnosis of brain masses: comparison of results of biopsy and resected surgical specimen. Neurosurgery 24: 160–165, 1989
Piepmeier JM, Christopher S: Low-grade gliomas-Introduction and overview. Journal of Neuro-Oncology 34: 1–3, 1997
Scerrati M, Roselli R, Iacoangeli M, Pompucci A, Rossi GF: Prognostic factors in low grade (WHO grade II) gliomas of the cerebral hemispheres: the role of surgery. J Neurol Neurosurg Psychiatry 61: 291–296, 1996
Berger MS, Deliganis AV, Dobbins J, Keles GE: The effect of extent of resection on recurrence in patients with low grade cerebral hemisphere gliomas. Cancer 74: 1784–17891, 1994
Karim AB, Maat B, Hatlevoll R, Menten J, Rutten EH, Thomas DG, Mascarenhas F, Horiot JC, Parvinen LM, van Reijn M, Jager JJ, Fabrini MG, van Alphen AM, Hamers HP, Gaspar L, Noordman E, Pierart M, van Glabbeke M: A randomized trial on dose-response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) Study 22844. Int J Radiat Oncol Biol Phys 36: 549–556, 1996
Piepmeier J, Christopher S, Spencer D, Byrne T, Kim J, Knisel JP, Lacy J, Tsukerman L, Makuch R: Variations in the natural history and survival of patients with supratentorial low-grade astrocytomas. Neurosurgery 38: 872–878; discussion 878–9, 1996
Lunsford LD, Somaza S, Kondziolka D, Flickinger JC: Survival after stereotactic biopsy and irradiation of cerebral nonanaplastic, nonpilocytic astrocytoma. J Neurosurg 82: 523–529, 1995
Lunsford LD, Somaza S, Kondziolka D, Flickinger JC: Brain astrocytomas: biopsy, then irradiation. Clin Neurosurg 42: 464–79, 1995
Bernstein M, Parrent AG: Complications of CT-guided stereotactic biopsy of intra-axial brain lesions. J Neurosurg 81: 165–168, 1994
Jeremic B, Grujicic D, Antunovic V, Djuric L, Stojanovic M, Shibamoto Y: Influence of extent of surgery and tumor location on treatment outcome of patients with glioblastoma multiforme treated with combined modality approach. J Neurooncol 21: 177–185, 1994
Karnofsky DA, Abelmann WH, Craver LS, Burchenal JH: The use of nitrogen mustards in the palliative treatment of carcinoma with particular reference to bronchogenic carcinoma. Cancer 1: 634–656, 1948
Ammirati M, Vick N, Liao YL, Ciric I, Mikhael M: Effect of the extent of surgical resection on survival and quality of life in patients with supratentorial glioblastomas and anaplastic astrocytomas. Neurosurgery 21: 201–206, 1987
Winger MJ, Macdonald DR, Cairncross JG: Supratentorial anaplastic gliomas in adults. The prognostic importance of extent of resection and prior low-grade glioma. J Neurosurg 71: 487–493, 1989
Aiken RD: Quality-of-life issues in patients with malignant gliomas. Semin Oncol 21: 273–275, 1994
Murray KJ, Nelson DF, Scott C, Fischbach AJ, Porter A, Farnan N, Curran WJ, Jr.: Quality-adjusted survival analysis of malignant glioma. Patients treated with twice-daily radiation (RT) and carmustine: a report of Radiation Therapy Oncology Group (RTOG) 83–02. Int J Radiat Oncol Biol Phys 31: 453–459, 1995
Lyons GJ: The 'PRESTON Profile'-the first diseasespecific tool for assessing quality of life in patients with malignant glioma. Disabil Rehabil 18: 460–468, 1996
Osoba D, Aaronson NK, Muller M, Sneeuw K, Hsu MA, Yung WK, Brada M, Newlands E: The development and psychometric validation of a brain cancer quality-of-life questionnaire for use in combination with general cancer-specific questionnaires. Qual Life Res 5: 139–150, 1996
Coffey RJ, Lunsford LD, Taylor FH: Survival after stereotactic biopsy of malignant gliomas. Neurosurgery 22: 465–473, 1988
Kreth FW, Warnke PC, Scheremet R, Ostertag CB: Surgical resection and radiation therapy versus biopsy and radiation therapy in the treatment of glioblastoma multiforme. J Neurosurg 78: 726–762, 1993
Shapiro WR, Green SB, Burger PC, Mahaley MS, Jr., Selker RG, VanGilder JC, Robertson JT, Ransohoff J, Mealey J, Jr., Strike TA, Pistenmaa DA: Randomized trial of threes chemotherapy regimens and two radiotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma. Brain Tumor Cooperative Group Trial 8001. J Neurosurg 71: 1–9, 1989
Simpson JR, Horton J, Scott C, Curran WJ, Rubin P, Fischbach J, Isaacson S, Rotman M, Asbell SO, Nelson JS, Weinstein AS, Nelson DF: Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive Radiation Therapy Oncology Group (RTOG)clinical trials. Int J Radiat Oncol Biol Phys 26: 239–244, 1993
Devaux BC, O'Fallon JR, Kelly PJ: Resection, biopsy, and survival in malignant glial neoplasms. A retrospective study of clinical parameters, therapy, and outcome. J Neurosurg 78: 767–775, 1993
Halperin EC, Gaspar L, Imperato J, Salter M, Herndon Jd, Dowling S: An analysis of radiotherapy data from the CNS cancer consortium's randomized prospective trial comparing AZQ to BCNU in the treatment of patients with primary malignant brain tumors. The CNS cancer consortium. Am J Clin Oncol 16: 277–283, 1993
Vecht CJ, Avezaat CJ, van Putten WL, Eijkenboom WM, Stefanko SZ: The influence of the extent of surgery on the neurological function and survival in malignant glioma. A retrospective analysis in 243 patients. J Neurol Neurosurg Psychiatry 53: 466–471, 1990
Kelly PJ, Hunt C: The limited value of cytoreductive surgery in elderly patients with malignant gliomas. Neurosurgery 34:62–66; discussion 66–7, 1994
Shaw EG, Scheithauer BW, O'Fallon JR: Supratentorial gliomas: a comparative study by grade and histologic type. J Neurooncol 31: 273–278, 1997
Daumas-Duport C, Scheithauer BW, Kelly PJ: A histologic and cytologic method for the spatial definition of gliomas. Mayo Clin Proc 62: 435–449, 1987
Kelly PJ, Daumas-Duport C, Scheithauer BW, Kall BA, Kispert DB: Stereotactic histologic correlations of computed tomography-and magnetic resonance imaging-defined abnormalities in patients with glial neoplasms. Mayo Clin Proc 62: 450–459, 1987
Quigley MR, Maroon JC: The relationship between survival and the extent of the resection in patients with supratentorial malignant gliomas. Neurosurgery 29: 358–385; discussion 388–9, 1991
Nazzaro JM, Neuwelt EA: The role of surgery in the management of supratentorial intermediate and high-grade astrocytomas in adults. J Neurosurg 73: 331–344, 1990
Ciric I, Ammirati M, Vick N, Mikhael M: Supratentorial gliomas: surgical considerations and immediate postoperative results. Gross total resection versus partial resection. Neurosurgery 21: 21–26, 1987
Hoshino T, Wilson C, Rosenblum M, Baker M: Chemotherapeutic implications of growth fraction and cell cycle time in glioblastoma. J Neurosurg 43: 127–135, 1975
Dhami MS, Bona RD, Calogero JA, Hellman RM: Venous thromboembolism and high grade gliomas. Thromb Haemost 70: 393–396, 1993
Quevedo JF, Buckner JC, Schmidt JL, Dinapoli RP, O'Fallon JR: Thromboembolism in patients with high-grade glioma. Mayo Clin Proc 69: 329–332, 1994
Gunel M, Piepmeier J: Management of low grade gliomas. Contemporary Neurosurgery 19: 1–6, 1997
Berger MS: The impact of technical adjuncts in the surgical management of cerebral hemispheric low-grade gliomas of childhood. J Neurooncol 28: 129–155, 1996
Demb JB, Desmond JE, Wagner AD, Vaidya CJ, Glover GH, Gabrieli JD: Semantic encoding and retrieval in the left inferior prefrontal cortex: a functional MRI study of task difficulty and process specificity. J Neurosci 15: 5870–5878, 1995
Righini A, de Divitiis O, Prinster A, Spagnoli D, Appollonio I, Bello L, Scifo P, Tomei G, Villani R, Fazio F, Leonardi 302 M: Functional MRI: primary motor cortex localization in patients with brain tumors. J Comput Assist Tomogr 20: 702–708, 1996
Pujol J, Vendrell P, Deus J, Kulisevsky J, Marti-Vilalta JL, Garcia C, Junque C, Capdevila A: Frontal lobe activation during word generation studied by functional MRI. Acta Neurol Scand 93: 403–10, 1996
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Vives, K.P., Piepmeier, J.M. Complications and Expected Outcome of Glioma Surgery. J Neurooncol 42, 289–302 (1999). https://doi.org/10.1023/A:1006163328765
Issue Date:
DOI: https://doi.org/10.1023/A:1006163328765